Best Selling Medicine 
Overview
Trajenta Duo 2.5/850 Mg is a potent combination medication designed to keep blood sugar levels under control. This drug has two active ingredients: linagliptin (2.5 mg) and metformin (500 mg), which work together to help control blood glucose in people whose diabetes cannot be successfully managed with diet, exercise, or a single prescription.
To effectively manage type 2 diabetes, a complete approach to blood sugar control is required, and Trajenta Duo 2.5/850 mg provides a dual-action solution to help with this.
This oral tablet combines two potent medications—linagliptin and metformin to help people maintain healthy blood glucose levels by targeting distinct pathways in the body.
Trajenta Duo is often used when diet, exercise, and single-drug therapy do not effectively manage blood sugar.
How Trajenta Duo 2.5/850 Mg Works?
The combination of linagliptin and metformin provides a powerful method for reducing excessive blood sugar levels in type 2 diabetic patients.
Metformin is a well-known biguanide that lowers glucose synthesis in the liver, improves insulin sensitivity, and allows the body to use glucose more efficiently.
These medications work together to lower blood sugar levels, particularly after meals, and minimize the risk of long-term diabetic consequences such as nerve damage, renal illness, and cardiovascular problems.
How To Take Trajenta Duo 2.5/850 Mg?
Trajenta Duo 2.5/850 mg is typically used once or twice a day with meals to reduce the risk of gastrointestinal side effects. It is critical that you strictly stick to your doctor’s dosing guidelines.
For best results, use it in conjunction with a healthy diet and exercise program. Regular monitoring of blood sugar levels is also required to confirm that the medicine is working as planned.
How Trajenta Duo 2.5/850 Mg Works?
Trajenta Duo 2.5/500 Mg combines two distinct mechanisms to manage high blood sugar:
Linagliptin is a DPP-4 inhibitor that works by increasing the levels of incretins, natural hormones that help regulate insulin secretion.
Linagliptin boosts the release of insulin after meals and suppresses the production of glucose by the liver, particularly after eating, helping to lower post-meal blood sugar spikes.
Key Benefits
Trajenta Duo 2.5/850 Mg, which combines linagliptin and metformin, provides a two-pronged strategy for lowering blood glucose levels by enhancing insulin secretion while decreasing glucose synthesis in the liver.
Effective Post-Meal Glucose Management: Linagliptin reduces post-meal blood sugar increases, allowing for improved control of blood sugar levels after eating. Metformin enhances insulin sensitivity by making cells more sensitive to insulin and lowering insulin resistance.
